All In MedTech

FDA Clearance Tracker · P050027

KARL STORZ PHOTODYNAMIC DIAGNOSTIC D-LIGHT C (PDD) SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: May 28, 2010 (this decision)Source: openFDAMethods & limitations

PMAFirst of its product code

Decided

May 28, 2010

Approved

Time to decision

1,762 days

Received Jul 31, 2005. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P050027
Device name
KARL STORZ PHOTODYNAMIC DIAGNOSTIC D-LIGHT C (PDD) SYSTEM
Applicant location
El Segundo, CA
Received
Jul 31, 2005
Decided
May 28, 2010
Decision
Approved
Supplements
35 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code OAY

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE KARL STORZPHOTODYNAMIC DIAGNOSTIC D-LIGHT C (PDD) SYSTEM. THE KARL STORZ PHOTODYNAMIC DIAGNOSTIC D-LIGHTC (PDD) SYSTEM IN COMBINATION WITH THE OPTICAL IMAGING DRUG CYSVIEW(HEXAMINOLEVULINATE HYDROCHLORIDE) FOR INTRAVESICAL SOLUTION IS INDICATED FOR PHOTODYNAMIC BLUELIGHT CYSTOSCOPY, AS AN ADJUNCT TO WHITE LIGHT CYSTOSCOPY FOR THE DETECTION OF NON-MUSCLE INVASIVEPAPILLARY CANCER OF THE BLADDER IN PATIENTS SUSPECTED OR KNOWN TO HAVE THE LESION ON THE BASIS OF A PRIOR CYSTOSCOPY.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • This is the earliest decision in FDA's data under product code OAY (Light source system, diagnostic endoscopic).
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for KARL STORZ Endoscopy-America, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.